Jeff Hall

In a recent interview, Connie Lehman, MD, PhD, discussed key changes to the National Comprehensive Cancer Network (NCCN) guidelines on breast cancer screening, including the use of AI-powered five-year risk assessment beginning at the age of 35.

The Philips Spectral CT Verida system reportedly provides reconstruction of 145 images per second, allowing entire CT exams to appear in less than 30 seconds.

Employing the SwiftMR software with deep learning reconstruction solutions from original equipment manufacturers (OEMs) may provide additional sequence coverage as well as scan time reduction.

In recent interviews with Diagnostic Imaging, Andrew Del Gaizo, MD, Nick Galante, MD and Marc Succi, MD, shared their perspective on the recent comment from NYC Health and Hospitals CEO Mitchell Katz, MD, about potentially replacing radiologists with AI.

In a recent interview, Marc Succi, MD, discussed findings from a new study examining the clinical reasoning capabilities of 21 large language models (LLMs), including GPT-5, Grok 4 and Claude 4.5 Opus.

In a new podcast episode, interventional radiologist Suresh Vedantham, MD, FSIR, discussed the use of iliac vein stent placement for addressing the severity of post-thrombotic syndrome (PTS) and new multicenter study findings presented at the Society for Interventional Radiology (SIR) 2026 Annual Scientific Meeting.

Catch up on the top radiology content of the past week.

In a recent interview, Lior Fisher, MD, discussed new research findings for AI software that may enable single view ultrasound detection of valvular and ventricular dysfunction by non-cardiologists.

In a time-independent test set from a new retrospective study, gadoxetic-acid enhanced MRI provided nearly 38 percent higher sensitivity for detecting sub-centimeter hepatocellular carcinoma recurrence (HCC) in contrast to extracellular contrast agent-enhanced MRI.

The compact NeedleVue Mini, which reportedly offers advanced guidance for existing ultrasound systems, will be among the NeedleVue platforms showcased at the Society of Interventional Radiology (SIR) Annual Meeting in Toronto.

For patients with cardiac dysfunction related to neoadjuvant chemotherapy for invasive breast cancer, new MRI research shows increased risks for concurrent decreases in total brain volume and white matter volume.

The neuropacs™ MRI-based AI software provided a 96 percent or better AUROC for differentiating between Parkinson’s disease, atypical parkinsonism, multiple system atrophy Parkinsonian variant and progressive supranuclear palsy, according to a prospective multicenter study published in JAMA Neurology.

There was no statistically significant difference in sensitivity rates for lesion detection between breast MRI scans with minimum or mild background parenchymal enhancement (BPE) and those with moderate or marked BPE, according to a newly published study involving over 300 women.

Catch up on the top radiology content of the past week.

In a recent interview, Jeremie Calais, MD, PhD, shared his perspective on recent research that compared the risk stratification capabilities of nomogram models incorporating PSMA PET data to established clinical risk scoring models from the European Association of Urology and the National Comprehensive Cancer Network (NCCN).

Pre-op MRI detection of seminal vesicle invasion was associated with a greater than five times higher likelihood of metastatic failure for patients undergoing radical prostatectomy, according to a newly published meta-analysis.

The CT-based True Definition DL software reportedly facilitates enhanced efficiency and high-resolution visualization for musculoskeletal, pulmonary and inner ear imaging.

For people with a history of heavy smoking, detection of significant incidental findings (SIFs) on low-dose computed tomography (LDCT) screening scans was associated with a 13.89 per 1000 marginal risk difference for extrapulmonary cancer in contrast to those with no SIFs, according to a study involving over 26,000 people.

The updated version 4.5.0. software for the Breast Acoustic CT platform reportedly facilitates improved spatial resolution in reflection imaging and enhanced capabilities for imaging of small breasts and breasts with implants.

Over a 10-year period, radiology report turnaround times for Medicare beneficiaries increased 113 percent with a total 87 percent increase occurring in 2022 and 2023, the last two years of a newly published retrospective study.

In a recent interview, Joseph Cavallo, MD, and Marla Sammer, MD, discussed the dearth of AI applications for pediatric imaging, new research evaluating adjunctive AI triage for CT detection of intracranial hemorrhages in children six and older, and going beyond the data points to ascertain the impact of AI on patient care.

In a recent interview, James Nagarajah, M.D., discussed new phase 2 research demonstrating significantly delayed disease progression in a cohort of patients with oligometastatic hormone-sensitive prostate cancer treated with 177-Lu-PSMA-617 and complete remission in nearly a quarter of these patients.

Reportedly trained on over 21 million images, Butterfly Network’s AI-enabled Gestational Age tool reportedly provides reliable automated age assessments between 16 and 37 weeks.

Catch up on the top radiology content of the past week.

Providing automated tracking and image guidance of the Edwards PASCAL Ace mitral valve repair device, the DeviceGuide reportedly enables integration of live ultrasound and X-ray images into a single view.

In a new podcast episode, Jennifer Frontera, M.D., discussed new research demonstrating a significantly higher prevalence of mild cognitive impairment in patients with Long Covid.

After a 2009 recommendation from the United States Prevention Services Task Force (USPSTF) against routine mammography screening for women 40-49 years of age, there was an approximate eight to 10 percent decline in mammography use for women in their 40s across different demographic subgroups, according to new research.

The DeepEcho Blind Sweep Platform reportedly automates a variety of key prenatal ultrasound measurements including fetal heart rate, placental location and gestational age.

In a recent interview, Louise Emmett, MBChB, FRACP, FAANMS, MD, discussed recent findings from the Co-PSMA trial demonstrating enhanced detection of biochemical recurrence of prostate cancer with the PET agent 64Cu-SAR-bisPSMA.

Offering high-resolution 3D imaging, the MARS Bioimaging Extremity Scanner System reportedly enhances the visualization of bone, soft tissue, blood vessels and metallic implants.